Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
102.50    -2.00 (-1.91%)
Bid:
102.00
Ask:
103.50
Spread: 1.50 (1.471%)
Market Cap: £299.53m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

AGM Statement

23 May 2023 07:00

RNS Number : 2337A
Big Technologies PLC
23 May 2023
 

 

23 May 2023

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

AGM Statement

 

Big Technologies plc, the UK-based, remote people monitoring technology company provides the following trading update ahead of its Annual General Meeting ("AGM") in London later today.

At the meeting, Simon Collins, Chair of Big Technologies plc will make the following statement:

"Since the announcement of our full year results, the Board is pleased to report that the Group continues to grow its revenues and that performance over the first four months of 2023 has been in line with expectations.

The pipeline of future opportunities remains strong and the Board is confident of continued growth and cash generation for the year ahead.

In the four months ending April 2023, we have recorded unaudited consolidated revenue of £18.5 million, an increase of 33% versus the same period in 2022. This performance, coupled with good visibility into the second half of the year, leads to our expectations for 2023 being unchanged and the Board remains confident of delivering results in line with current market expectations(1).

Our products and technology deliver benefits for society across the globe. In the criminal justice sector our products facilitate a shift towards rehabilitative community-based sentencing which reduces recidivism and keep communities safer. In the remote care sector our technology helps people live happier, healthier and more independent lives.

Market drivers for continued growth across both sectors remains strong. With our clear strategy and market-leading products, we are well positioned for growth and continued cash generation during 2023 and beyond."

(1) Latest company compiled view of market expectations show adjusted EBITDA of £32.7 million to £34.7 million (stated before share-based payments).

 For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel / Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFDEEDSELI
Date   Source Headline
13th Jun 20224:41 pmRNSSecond Price Monitoring Extn
13th Jun 20224:36 pmRNSPrice Monitoring Extension
10th Jun 20224:41 pmRNSSecond Price Monitoring Extn
10th Jun 20224:35 pmRNSPrice Monitoring Extension
31st May 20227:00 amRNSDirector/PDMR Shareholding
27th May 202212:13 pmRNSResult of AGM
27th May 20227:00 amRNSAGM Statement
12th May 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSIncrease in share capital
22nd Apr 20227:00 amRNS2021 Annual Report and Notice of AGM
25th Mar 20222:57 pmRNSDirector/PDMR Shareholding
25th Mar 20222:51 pmRNSDirector/PDMR Shareholding
24th Mar 202210:00 amRNSIncrease in share capital
24th Mar 20227:00 amRNS2021 Preliminary audited results
8th Feb 20224:40 pmRNSSecond Price Monitoring Extn
8th Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSTrading Statement
18th Jan 20227:00 amRNSIncrease in share capital
5th Jan 202210:14 amRNSDirector/PDMR Shareholding
10th Dec 202111:13 amRNSIncrease in share capital
30th Nov 20214:36 pmRNSPrice Monitoring Extension
18th Nov 20218:02 amRNSContract
4th Nov 20219:03 amRNSHolding(s) in Company
15th Oct 20212:28 pmRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSIncrease in share capital
23rd Sep 20217:00 amRNSHalf-year Report
13th Sep 20217:00 amRNSPreferred Bidder
28th Jul 20217:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.